Nesiritide: A new therapy for the treatment of heart failure

ISSN： 1530-7905

Source： Cardiovascular Toxicology, Vol.3, Iss.1, 2003-03, pp. : 37-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment with B-Type Natriuretic Peptide for Chronic Decompensated Heart Failure: Insights Learned from the Follow-Up Serial Infusion of Nesiritide (FUSION) Trial

By Yancy Clyde

Heart Failure Reviews, Vol. 9, Iss. 3, 2005-01 ,pp. : 209-216

Springer Publishing Company

Access to resources Recommend Favorite

Exploring New Treatment Strategies in Heart Failure

By SWEDBERG KARL

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 44-48

Informa Healthcare

Access to resources Recommend Favorite

Serelaxin: New Investigational Treatment in Acute Heart Failure

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 11, Iss. 3, 2013-09 ,pp. : 243-248

Bentham Science Publishers

Access to resources Recommend Favorite

Cellular Therapy for Heart Failure

Current Cardiology Reviews, Vol. 12, Iss. 3, 2016-07 ,pp. : 195-215

Bentham Science Publishers

Access to resources Recommend Favorite

Acute Heart Failure and Atrial Fibrillation: Insights From the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND‐HF) Trial

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 8, 2015-08 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite